Carpal Tunnel Injection for Pain Relief
Carpal Tunnel Injection
Carpal tunnel syndrome occurs when the median nerve is compressed within the carpal tunnel at the wrist. A corticosteroid injection can reduce local inflammatory symptoms and may provide short-term symptom improvement for selected patients.
The injection does not permanently decompress the median nerve and should not be described as a long-term cure. The 2024 AAOS guideline concludes that corticosteroid injection does not provide long-term improvement of carpal tunnel syndrome.
When Is Injection Considered?
Injection may be discussed for selected mild-to-moderate symptoms, temporary symptom control, or when other nonoperative measures are being considered. Progressive weakness, thenar atrophy, severe electrodiagnostic abnormalities, persistent symptoms, or other concerning findings may prompt surgical evaluation.
Risks
Potential risks include temporary pain, infection, bleeding, skin depigmentation or fat atrophy, transient blood-glucose elevation, tendon injury, and median-nerve injury. Ultrasound guidance may be used to improve visualization of the nerve and surrounding structures.
Clinical Evidence, Limitations & Patient Selection
Corticosteroid injection can provide short-term symptom improvement in carpal tunnel syndrome, but AAOS finds strong evidence that it does not provide long-term improvement.
Important limitation: Injection does not permanently decompress the median nerve. Progressive motor deficit or severe/persistent disease may require surgical evaluation.
Every procedure has potential risks, and individual benefit cannot be guaranteed. Recommendations at Solutions in Pain are based on the diagnosis, examination, relevant imaging, prior treatment, medical history, medications, patient goals, current evidence, and applicable payer requirements.
Selected Evidence & Guidelines
Patient-education content updated September 2026. This information does not replace an individualized medical evaluation or informed-consent discussion.